Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative esketamine bundled management in open cervical cancer surgery
ChiCTR2300073125Phase 4Not yet recruiting
- Sponsor
- Tumor Hospital Affiliated to Guizhou Medical University
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine in Postoperative gastrointestinal dysfunction (POGD) and postoperative pain (3 arms), sponsored by Tumor Hospital Affiliated to Guizhou Medical University. Primary endpoint: Incidence of postoperative gastrointestinal dysfunction. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Postoperative gastrointestinal dysfunction (POGD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2300073125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073125.